AngioDynamics, Inc. - Common Stock (ANGO)
Frequently Asked Questions About AngioDynamics, Inc. - Common Stock (ANGO)
Does AngioDynamics focus on sustainability?
Yes, AngioDynamics is committed to sustainable practices, which include reducing waste, optimizing supply chain processes, and developing environmentally friendly products. The company recognizes the importance of sustainability in the healthcare sector.
How can investors find financial information about AngioDynamics?
Investors can find financial information about AngioDynamics through the Investor Relations section on the company’s official website. The site offers access to quarterly earnings reports, SEC filings, and stock performance data.
How does AngioDynamics contribute to medical innovation?
AngioDynamics contributes to medical innovation by investing in research and development to create advanced medical technologies that improve treatment options for patients with cancer and vascular conditions. The company's commitment to innovation is evidenced by its array of patented products and ongoing clinical studies.
How does AngioDynamics ensure product quality?
The company ensures product quality through a comprehensive quality management system, continuous monitoring of manufacturing processes, and adherence to stringent regulatory standards. Regular audits and inspections are also conducted to maintain quality assurance.
In which markets does AngioDynamics operate?
AngioDynamics primarily operates in the global healthcare market, focusing on vascular access, oncology, and surgical markets. Their products are distributed across North America, Europe, and Asia-Pacific regions.
What are AngioDynamics' main product lines?
AngioDynamics' main product lines include vascular access products, such as catheters and ports, ablation technologies like microwave and radiofrequency systems, and a range of other medical devices designed for minimally invasive procedures.
What does AngioDynamics, Inc. do?
AngioDynamics, Inc. is a leading medical technology company that specializes in developing innovative solutions for treating cancer and vascular conditions. The company offers a wide range of products, including vascular access devices, ablation technologies, and other therapies designed to improve patient outcomes.
What is AngioDynamics' approach to clinical research?
AngioDynamics takes a rigorous approach to clinical research by conducting studies to evaluate the safety and effectiveness of its products. This research helps to support regulatory approvals and provides evidence of improved outcomes for patients.
What is AngioDynamics' stock symbol?
The stock symbol for AngioDynamics, Inc. is ANGO. It is traded on the Nasdaq Stock Market, allowing investors to buy and sell shares in the company.
What is AngioDynamics' strategy for growth?
AngioDynamics' growth strategy focuses on innovation, expanding its product offerings through R&D, and acquiring complementary businesses to enhance its market presence. The company also aims to strengthen its distribution channels for better market access.
What is the mission of AngioDynamics?
The mission of AngioDynamics is to provide high-quality medical devices that improve patients' lives while addressing the needs of healthcare professionals. The company aims to deliver innovative solutions that enhance procedural efficiency and patient outcomes.
What recent developments has AngioDynamics announced?
AngioDynamics frequently announces new product launches, partnerships, and strategic acquisitions aimed at enhancing its product portfolio. For the latest updates on recent developments, one can check their official website or press releases.
What type of community engagement does AngioDynamics participate in?
AngioDynamics is involved in community engagement through various initiatives, including health awareness campaigns, partnerships with nonprofit organizations, and volunteerism by employees. This involvement demonstrates the company's commitment to social responsibility.
What types of certifications do AngioDynamics products have?
AngioDynamics products are certified and comply with various international quality standards, including ISO 13485 for medical devices. These certifications reflect the company's commitment to quality and regulatory compliance throughout product development.
When was AngioDynamics founded?
AngioDynamics was founded in 1988. Over the years, the company has grown significantly and expanded its product offerings through a combination of innovation and strategic acquisitions.
Where is AngioDynamics, Inc. headquartered?
AngioDynamics, Inc. is headquartered in Queensbury, New York. This location is central to the company's operations and provides access to a skilled workforce and industry partners.
Who are AngioDynamics' main competitors?
AngioDynamics operates in a competitive landscape, with key competitors including Medtronic, Boston Scientific, and Abbott Laboratories. These companies also focus on developing innovative medical devices for vascular access and ablation therapies.
Who is the CEO of AngioDynamics?
As of the most recent information, the CEO of AngioDynamics is James (Jim) E. Clemmer. Under his leadership, the company has focused on growth strategies and product development aligned with market demands.
What is the current price of AngioDynamics, Inc. - Common Stock?
The current price of AngioDynamics, Inc. - Common Stock is 8.870
When was AngioDynamics, Inc. - Common Stock last traded?
The last trade of AngioDynamics, Inc. - Common Stock was at 2:55 pm EDT on April 4th, 2025
What is the market capitalization of AngioDynamics, Inc. - Common Stock?
The market capitalization of AngioDynamics, Inc. - Common Stock is 341.00M
How many shares of AngioDynamics, Inc. - Common Stock are outstanding?
AngioDynamics, Inc. - Common Stock has 38.44M shares outstanding.